From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. Hepatitis>
  4. Archives

Hepatitis: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

Items 176-200 of 401 are shown

Promising New Drug for Hepatitis C Infection

A single dose of a novel compound led to sustained virologic suppression.

Interleukin-28B and Clearance of Hepatitis C Virus in HIV-Coinfected Patients

Sequences near the <$EMPH_O>IL-28B<$EMPH_C> gene predict response to HCV therapy in HCV/HIV-coinfected patients.

Telaprevir for Patients with Previously Treated Hepatitis C Virus Infection

Patients who received telaprevir-based regimens achieved higher rates of sustained virologic response than patients who received standard care.

Does Alcohol Consumption Worsen Nonalcoholic Steatohepatitis?

In a rat study, moderate alcohol intake had deleterious effects on NASH.

Does Abacavir Use Influence HCV Treatment Response?

Abacavir use was not associated with reduced virologic response rates (either early or sustained) in this relatively small retrospective cohort study.

Isolated Positivity for Antibodies to Hepatitis B Core Antigen in HIV-Infected Patients

Many HIV-infected patients with isolated anti-HBc positivity do not have an anamnestic response to hepatitis B virus vaccine, which suggests that they might not have been previously exposed to the virus.

Hepatocellular Carcinoma and Hepatitis C Virus–Related Cirrhosis

Among cirrhotic HCV patients, those who achieved sustained virologic response from interferon therapy had lower risk for developing HCC than nonresponders.

Rifaximin for Maintaining Remission in Hepatic Encephalopathy

During a 6-month study, rifaximin was more effective than placebo in reducing breakthrough episodes in cirrhotic patients.

Predicting Fibrosis Progression in Nonalcoholic Steatohepatitis

Several independent risk factors predicted progression in obese NASH patients.

Hepatitis C Virus and HIV Coinfection: Translating New Discoveries into Clinical Practice

The 2010 Retrovirus Conference enhanced our understanding of the biology, clearance, and treatment of hepatitis C virus infection.

Management of Healthcare Workers Who Are Infected with Bloodborne Pathogens

This updated document provides guidance on restricting the patient-care activities of such workers.

Tenofovir for Treatment-Experienced Patients with Hepatitis B Virus Infection

Monotherapy was effective in patients who failed previous therapy with lamivudine or adefovir.

Peginterferon Alfa-2a vs. Alfa-2b for Hepatitis C

In two head-to-head trials, peginterferon alfa-2a regimens provided higher rates of sustained virologic response.

Prevalence and Incidence of HBV Infection in an HIV-Positive Cohort

Hepatitis B virus infection continues to be a major problem in a U.S. military cohort of HIV-infected individuals. More effective "prevention for positives" is needed.

Briefly Noted

Neonatal cutis laxa, dyskeratosis congenita, and recurrent erythema multiforme

MicroRNA-Based Therapy Treats Hepatitis C Virus Infection in Primates

A new class of therapeutics offers hope for effective HCV treatment.

Coffee and Hepatitis C Virus Infection

Greater coffee consumption was associated with lower risk for liver disease progression.

WHO Updates HIV Treatment Recommendations

New WHO recommendations endorse earlier ART initiation for HIV-infected adolescents and adults and an even more-aggressive approach for those coinfected with TB or HBV.

Pain Control in Newborn Infants

Skin-to-skin contact plus 25% oral dextrose is the most effective procedural pain control in newborns.

Fibrosis Progression in Patients with Hepatitis C Infection

A gene-based cirrhosis risk score predicted liver fibrosis progression in male patients.

Does Chronic Hepatitis B Therapy Improve Long-Term Outcomes?

Treatment that resulted in biochemical or histologic response was associated with improved long-term outcomes.

Histological Disease in Chronic Hepatitis B Patients

Among patients with normal ALT levels and high viral loads, those older than 35 or with fluctuating ALT levels were more likely to experience clinically significant disease.

Influence of HCV Infection on Mortality in HIV-Infected Patients

HCV infection is associated with increased overall mortality, but not with AIDS-defining events, in HIV-infected patients.

Viramidine vs. Ribavirin for Hepatitis C Infection

The ribavirin prodrug viramidine failed to demonstrate noninferiority to ribavirin in achieving sustained virologic response rates.

Hepatitis E Outbreak Among Cruise Ship Passengers

Overall, 4% of passengers returning from a 3-month world cruise tested positive for recent HEV infection; one third of these individuals had symptomatic hepatitis.

Items 176-200 of 401 are shown

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?





Copyright © 2013. Massachusetts Medical Society. All rights reserved.